IMPORTANT ALERT: Halper Sadeh LLC Investigates AMED, SYNH, EMBK

Author's Avatar
Jul 03, 2023

NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Amedisys, Inc. ( AMED)’s sale to Optum for $101.00 per share. If you are an Amedisys shareholder, click here to learn more about your rights and options.

Syneos Health, Inc. ( SYNH)’s sale to a consortium of affiliates of Elliott Investment Management, Patient Square Capital, and Veritas Capital for $43.00 per share in cash. If you are a Syneos shareholder, click here to learn more about your rights and options.

Embark Technology, Inc. ( EMBK)’s sale to Applied Intuition, Inc. for $2.88 per share in cash. If you are an Embark shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

ti?nf=ODg2ODUzMiM1Njc1ODc1IzIxMjU4MTU=
Halper-Sadeh-LLC.png